Zobrazeno 1 - 10 of 305 pro vyhledávání: '"Süssmuth SD"'
1
Akademický článek
Safety of BI 1358894 in patients with major depressive disorder: Results and learnings from a phase II randomized decentralized clinical trial.
Autor: Reist C; Science 37, Culver City, CA, USA., Li P; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Le Nguyen T; Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield, CT, USA., Süssmuth SD; Boehringer Ingelheim International GmbH, Biberach an der Riss, Germany.
Publikováno v: Clinical and translational science [Clin Transl Sci] 2024 Dec; Vol. 17 (12), pp. e70102.
Zobrazit plný text záznamu
2
Akademický článek
Effects of a single dose of amisulpride on functional brain changes during reward- and motivation-related processing using task-based fMRI in healthy subjects and patients with major depressive disorder - study protocol for a randomized clinical trial.
Autor: Carstens L; MSB Medical School Berlin, Berlin, Germany., Popp M; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an Der Riss, Germany., Keicher C; Charité Research Organisation GmbH, Berlin, Germany., Hertrampf R; Charité Research Organisation GmbH, Berlin, Germany., Weigner D; MSB Medical School Berlin, Berlin, Germany., Meiering MS; MSB Medical School Berlin, Berlin, Germany. marvin.meiering@medicalschool-berlin.de., Luippold G; Clinical Development and Operations, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an Der Riss, Germany., Süssmuth SD; Medicine Therapeutic Area CNS-Retinopathies-Emerging Areas, Boehringer Ingelheim International GmbH, Biberach an Der Riss, Germany., Beckmann CF; Donders Institute, Centre for Medical Neuroscience, Radboud University Medical Centre, Nijmegen, Netherlands.; Centre for Functional MRI of the Brain (FMRIB), Nuffield Department of Clinical Neurosciences, Wellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.; SBGneuro Ltd, Littlemore, Oxford, UK., Wunder A; Translational Medicine and Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an Der Riss, Germany., Grimm S; MSB Medical School Berlin, Berlin, Germany.
Publikováno v: Trials [Trials] 2023 Nov 27; Vol. 24 (1), pp. 761. Date of Electronic Publication: 2023 Nov 27.
Zobrazit plný text záznamu
3
Akademický článek
Tryptophan catabolites and depression in the general population: results from the Gutenberg Health Study.
Autor: Michal M; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany. michal@uni-mainz.de.; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, University Medical Center of the Johannes Gutenberg University, 55131, Langenbeckstr. 1, Mainz, Germany. michal@uni-mainz.de., Schulz A; Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Wild PS; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, University Medical Center of the Johannes Gutenberg University, 55131, Langenbeckstr. 1, Mainz, Germany.; Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Koeck T; German Center for Cardiovascular Research (DZHK), Partner Site Rhine-Main, University Medical Center of the Johannes Gutenberg University, 55131, Langenbeckstr. 1, Mainz, Germany.; Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Münzel T; Center for Cardiology - Cardiology I, University Medical Center of the Johannes Gutenberg University, Mainz, Germany., Schuster AK; Department of Ophthalmology, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany., Strauch K; Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center, Johannes Gutenberg University, Mainz, Germany., Lackner K; Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Süssmuth SD; Clinical Development, uniQure NV, Allschwil, Switzerland.; Department of Neurology, Univeristy Hospital of Ulm University, Ulm, Germany., Niessen HG; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397, Biberach an Der Riss, Germany., Borta A; Clinical Development, uniQure NV, Allschwil, Switzerland., Allers KA; CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Birkendorfer Strasse 65, 88397, Biberach an Der Riss, Germany., Zahn D; Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany., Beutel ME; Department of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.
Publikováno v: BMC psychiatry [BMC Psychiatry] 2023 Jan 11; Vol. 23 (1), pp. 27. Date of Electronic Publication: 2023 Jan 11.
Zobrazit plný text záznamu
4
Akademický článek
Quantitative electroencephalography parameters as neurophysiological biomarkers of schizophrenia-related deficits: A Phase II substudy of patients treated with iclepertin (BI 425809).
Autor: Schultheis C; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany. christian.schultheis@boehringer-ingelheim.com., Rosenbrock H; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Mack SR; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Vinisko R; Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA., Schuelert N; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Plano A; Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Süssmuth SD; Boehringer Ingelheim International GmbH, Biberach an der Riss, Germany.
Publikováno v: Translational psychiatry [Transl Psychiatry] 2022 Aug 11; Vol. 12 (1), pp. 329. Date of Electronic Publication: 2022 Aug 11.
Zobrazit plný text záznamu
5
Akademický článek
The association between plasma tryptophan catabolites and depression: The role of symptom profiles and inflammation.
Autor: Milaneschi Y; Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, The Netherlands. Electronic address: y.milaneschi@ggzingeest.nl., Allers KA; CNS Diseases Research, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Beekman ATF; Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, The Netherlands., Giltay EJ; Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands., Keller S; Drug Metabolism & Pharmacokinetics, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Schoevers RA; University of Groningen, University Medical Center Groningen, Department of Psychiatry, Groningen, The Netherlands., Süssmuth SD; Therapeutic Area CNS-Retinopathies-Emerging Areas, Boehringer Ingelheim International GmbH, Biberach an der Riss, Germany., Niessen HG; Department of Translational Medicine & Clinical Pharmacology, Boehringer Ingelheim Pharma GmbH & Co. KG, Biberach an der Riss, Germany., Penninx BWJH; Department of Psychiatry, Amsterdam Public Health and Amsterdam Neuroscience, Amsterdam UMC/Vrije Universiteit, Amsterdam, The Netherlands.
Publikováno v: Brain, behavior, and immunity [Brain Behav Immun] 2021 Oct; Vol. 97, pp. 167-175. Date of Electronic Publication: 2021 Jul 09.
Zobrazit plný text záznamu
6
Akademický článek
Tick-Borne Encephalitis: A Differential Pattern of Intrathecal Humoral Immune Response and Inflammatory Cell Composition Compared with Other Viral CNS Infections.
Autor: Senel M; Department of Neurology, University of Ulm, 89081 Ulm, Germany., Rapp D; Department of Neurology, University of Ulm, 89081 Ulm, Germany., Mayer B; Institute of Epidemiology and Medical Biometry, Ulm University, 89075 Ulm, Germany., Jesse S; Department of Neurology, University of Ulm, 89081 Ulm, Germany., Süssmuth SD; Department of Neurology, University of Ulm, 89081 Ulm, Germany., Otto M; Department of Neurology, University of Ulm, 89081 Ulm, Germany., Lewerenz J; Department of Neurology, University of Ulm, 89081 Ulm, Germany., Tumani H; Department of Neurology, University of Ulm, 89081 Ulm, Germany.; Speciality Clinic of Neurology Dietenbronn, 88477 Schwendi, Germany.
Publikováno v: Cells [Cells] 2020 Sep 25; Vol. 9 (10). Date of Electronic Publication: 2020 Sep 25.
Zobrazit plný text záznamu
10
Akademický článek
CSF and blood levels of Neurofilaments, T-Tau, P-Tau, and Abeta-42 in amyotrophic lateral sclerosis: a systematic review and meta-analysis.
Autor: Agah, Elmira1,2 (AUTHOR), Mojtabavi, Helia2,3 (AUTHOR), Behkar, Atefeh4 (AUTHOR), Heidari, Arash5,6 (AUTHOR), Ajdari, Atra2 (AUTHOR), Shaka, Zoha2 (AUTHOR), Mousavi, Seyed Vahid1 (AUTHOR), Firoozeh, Negar7 (AUTHOR), Tafakhori, Abbas1 (AUTHOR) abbas.tafakhori@gmail.com, Rezaei, Nima2 (AUTHOR) rezaei_nima@yahoo.com
Publikováno v: Journal of Translational Medicine. 10/21/2024, Vol. 22 Issue 1, p1-15. 15p.
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje